Globus Medical Buys Higgs Boson Health to Add AI-Driven Digital Solutions
GMED sits 53% above its 52-week low of $54.15.
Summary
Globus Medical is acquiring Higgs Boson Health, a move aimed at integrating AI-driven digital solutions into its healthcare offerings. The deal aligns with the company's strategy to enhance patient care through technology. No financial terms were disclosed. This follows a strong Q2 2026 where revenue rose 5.9% to $789.6M and operating income more than doubled. The acquisition could expand Globus's digital health capabilities and open new growth avenues.
At the time of this announcement, GMED was trading at $82.96 on NYSE in the Life Sciences sector, with a market capitalization of approximately $11.1B. The 52-week trading range was $54.15 to $101.40. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.